ConductScience.org, home

Paper42436735

Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study.

Etherton-Beer C and 9 others. Ther Adv Drug Saf, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study. Papers, record 42436735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42436735

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study.
PubMed
Journal
Ther Adv Drug Saf
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Etherton-Beer CChristopherhttps://orcid.org/0000-0001-5148-0188
2Page ATAmy Theresahttps://orcid.org/0000-0002-2084-8469
3Quek HWHui Wenhttps://orcid.org/0000-0003-3851-179X
4Parkinson LLynne
5Naganathan VVasi
6Caughey GGillian
7Redfern JJulie
8Clifford RRhonda
9Hilmer SSarah
10Mangin DDeehttps://orcid.org/0000-0003-2149-9376

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134446273Anticholinergics and clinical outcomes amongst people with pre-existing dementia: A systematic review.Maturitas2021https://conductscience.org/library/papers/34446273PubMed
227288377Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity.BMJ Open2016https://conductscience.org/library/papers/27288377PubMed
338307120Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis.J Am Med Dir Assoc2024https://conductscience.org/library/papers/38307120PubMed
43558716A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.J Chronic Dis1987https://conductscience.org/library/papers/3558716PubMed
521479777Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).Qual Life Res2011https://conductscience.org/library/papers/21479777PubMed
625358236Comorbidity and dementia: a scoping review of the literature.BMC Med2014https://conductscience.org/library/papers/25358236PubMed
719647495Telephone interview for cognitive status: Creating a crosswalk with the Mini-Mental State Examination.Alzheimers Dement2009https://conductscience.org/library/papers/19647495PubMed
833639545Strategies to engage people with dementia and their informal caregivers in dyadic intervention: A scoping review.Geriatr Nurs2021https://conductscience.org/library/papers/33639545PubMed
934457093Home medicines reviews: a national survey of Australian accredited pharmacists' health service time investment.Pharm Pract (Granada)2021https://conductscience.org/library/papers/34457093PubMed
1026338170Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review.Curr Clin Pharmacol2015https://conductscience.org/library/papers/26338170PubMed
1137247404Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med study.Age Ageing2023https://conductscience.org/library/papers/37247404PubMed
1229327604Strategies to improve recruitment of people with dementia to research studies.Dementia (London)2019https://conductscience.org/library/papers/29327604PubMed
1337213440Linking Patients' Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway.J Patient Exp2023https://conductscience.org/library/papers/37213440PubMed
1431219179Polypharmacy among older Australians, 2006-2017: a population-based study.Med J Aust2019https://conductscience.org/library/papers/31219179PubMed
152760661Improving the sensitivity of the Barthel Index for stroke rehabilitation.J Clin Epidemiol1989https://conductscience.org/library/papers/2760661PubMed
1617452540A drug burden index to define the functional burden of medications in older people.Arch Intern Med2007https://conductscience.org/library/papers/17452540PubMed
1737603255Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER).Drugs Aging2023https://conductscience.org/library/papers/37603255PubMed
1830373460Patient engagement in research related to dementia: A scoping review.Dementia (London)2018https://conductscience.org/library/papers/30373460PubMed
1926530985A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.Trials2015https://conductscience.org/library/papers/26530985PubMed
2029177770Interventions to Improve Medicines Management for People with Dementia: A Systematic Review.Drugs Aging2017https://conductscience.org/library/papers/29177770PubMed

See all 33 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42436735

GET https://conductscience.org/api/papers/v1/42436735/references?page=2